Study guide

6.1 Psychiatry & Behavioral Medicine

Physician Assistant National Recertifying Exam PANRE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & PANRE Exam Overview

1.1 PANRE Exam Facts 1.2 Maintaining Certification & Eligibility 1.3 Content Blueprint & Study Strategy

2 Cardiovascular & Pulmonary Systems

2.1 Cardiovascular I: Ischemic, Heart Failure & Vascular 2.2 Cardiovascular II: Arrhythmias, Valvular & Other 2.3 Pulmonary

3 GI/Nutrition, Renal, Genitourinary & Reproductive

3.1 Gastrointestinal & Nutrition 3.2 Renal & Genitourinary 3.3 Reproductive

4 Endocrine, Hematologic & Infectious Diseases

4.1 Endocrine 4.2 Hematologic 4.3 Infectious Diseases

5 Musculoskeletal, Neurologic, Dermatologic & EENT

5.1 Musculoskeletal & Neurologic 5.2 Dermatologic 5.3 Eyes, Ears, Nose & Throat

6 Psychiatry, Emergent Topics & Final Review

6.1 Psychiatry & Behavioral Medicine 6.2 Emergent & Cross-Cutting Topics 6.3 High-Yield Review & Test Strategy

6.1 Psychiatry & Behavioral Medicine

Key Takeaways Explain This Topic AI

Psychiatry/Behavioral is weighted at 7% of the PANRE blueprint (about 17 of 240 scored items), so high-yield mastery of mood, anxiety, and psychotic disorders is exam-efficient.

Selective serotonin reuptake inhibitors (SSRIs) are first-line pharmacotherapy for major depressive disorder and most anxiety disorders; mood stabilizers or atypical antipsychotics are first-line for bipolar I disorder.

Active suicidal ideation with a plan, intent, or recent attempt is a do-not-miss emergency requiring constant observation and disposition before discharge.

Bupropion lowers the seizure threshold and is contraindicated in patients with active eating disorders or seizure disorders; SSRIs plus another serotonergic agent risk serotonin syndrome.

Attention-deficit/hyperactivity disorder (ADHD) requires symptom onset before age 12 in at least two settings; stimulants are first-line but warrant a cardiovascular history first.

Last updated: May 2026

Psychiatry & Behavioral Medicine

Behavioral health accounts for 7% of the PANRE blueprint — approximately 17 of the 240 scored questions. Because recertifying physician assistants (PAs) practice across primary care, urgent care, and inpatient settings, the National Commission on Certification of Physician Assistants (NCCPA) tests recognition, first-line management, and safety , not subspecialty psychiatry. Expect single-best-answer vignettes that hinge on a screening tool, a diagnostic time criterion, a drug class, or a contraindication.

This section concentrates on the patterns that recur every cycle. Master the diagnostic time thresholds , the first-line drug for each disorder , and the high-stakes adverse effects , and you will capture nearly all of the points available here.

Why This Topic Matters

Mood and anxiety disorders are among the most common conditions seen in any PA's panel, so the blueprint over-samples them within the 7%.

Suicide-risk and acute agitation items are written as must-not-miss safety questions; a single wrong disposition choice can be the difference on a borderline scaled score.

Psychopharmacology overlaps with the Cardiovascular and Emergent-Topics content, so this material compounds across the exam.

  • Mood Disorders
  • Major Depressive Disorder (MDD)

Diagnosis requires ≥ 5 of 9 symptoms for ≥ 2 weeks , with at least one being depressed mood or anhedonia (loss of interest). The mnemonic SIG E CAPS captures the symptom set: Sleep change, loss of Interest, Guilt, low Energy, Concentration deficit, Appetite change, Psychomotor change, Suicidality.

First-line pharmacotherapy: an SSRI (for example, sertraline, escitalopram). Serotonin-norepinephrine reuptake inhibitors (SNRIs) are reasonable alternatives.

Onset of effect: 4–6 weeks at a therapeutic dose before judging response. Counsel patients that early activation may precede mood improvement.

Black-box warning: increased suicidality risk in patients under 25 during initiation — schedule close follow-up.

Bipolar Disorder

Bipolar I requires at least one manic episode (≥ 1 week of elevated/irritable mood plus increased activity, often with psychosis or hospitalization).

Bipolar II requires a hypomanic episode plus a major depressive episode and never a full manic episode.

First-line: lithium, valproate, or an atypical antipsychotic. Do not give an antidepressant alone — it can precipitate a manic switch.

Lithium monitoring: narrow therapeutic index; check levels, renal function, and thyroid function. Toxicity presents with tremor, ataxia, confusion, and is potentiated by dehydration, thiazides, NSAIDs, and ACE inhibitors.

Anxiety, Trauma & Obsessive-Compulsive Disorders

Disorder Key Diagnostic Anchor First-Line Treatment

Generalized anxiety disorder (GAD) Excessive worry most days for ≥ 6 months SSRI or SNRI + cognitive behavioral therapy (CBT)

Panic disorder Recurrent unexpected panic attacks + 1 month of anticipatory worry SSRI; CBT; benzodiazepine only short-term/bridge

Post-traumatic stress disorder (PTSD) Symptoms > 1 month after trauma: intrusion, avoidance, hyperarousal, negative cognition SSRI/SNRI + trauma-focused psychotherapy

Obsessive-compulsive disorder (OCD) Obsessions and/or compulsions that are time-consuming/impairing SSRI (often higher dose) + exposure and response prevention

Acute stress disorder Same trauma symptoms lasting 3 days to 1 month Supportive care; trauma-focused CBT

Benzodiazepine caution: effective for acute anxiety but carry tolerance, dependence, and — in older adults — fall and delirium risk. They are not first-line maintenance therapy. Avoid combining with opioids (additive respiratory depression).